An ongoing asbestos crisis within Philadelphia public schools has another chapter. The Philadelphia City Council approved additional regulations and steps for inspecting asbestos...
Read PostImports of asbestos into the United States took a steep fall in 2021 – promising news – but are trending upwards so far in 2022. Asbestos, a known carcinogen, can cause the...
Read PostUPDATE: O-I Glass Asbestos Trust Fund Approved for Past Insulation Products
By: Devin Golden
May 17, 2022
This post was updated May 17, 2022: O-I Glass received court approval from a bankruptcy court in Delaware to move forward with its $610 million asbestos trust fund. This fund will...
Read PostProton Radiation Therapy Growing in Popularity for Mesothelioma and Lung Cancer
By: Devin Golden
May 13, 2022
The newest type of radiation therapy is proton beam radiation therapy, often shortened to proton radiation. It’s also growing in popularity for use treating a number of...
Read PostOne of the concerns for some people with cancer is whether COVID-19 vaccinations would work during cancer treatment. Would the combination of the two offset each other or make the...
Read PostThe United States Food and Drug Administration (FDA) issued a world-changing proposal that could significantly reduce the number of cancer cases in the coming years. The FDA...
Read PostIntraoperative Chemotherapy With Mesothelioma Surgery Results in Longer Life
By: Camryn Keeble
April 26, 2022
A recent study shows any type of surgery combined with hyperthermic intrathoracic chemotherapy (HITHOC) results in improved disease-free intervals and overall survival rates for...
Read PostAnetumab Ravtansine Treatment Underperforms in Mesothelioma Clinical Trial
By: Devin Golden
April 22, 2022
A phase 2 clinical trial testing anetumab ravtansine against the chemotherapy drug vinorelbine did not provide the results investigators hoped for mesothelioma. Anetumab...
Read PostCheckmate 743: Immunotherapy for Mesothelioma Stabilizes Quality of Life
By: Camryn Keeble
April 14, 2022
According to clinical trial Checkmate 743, mesothelioma immunotherapy drugs nivolumab (Opdivo) and ipilimumab (Yervoy), when taken together, result in a higher quality of life...
Read PostDr. Joseph Friedberg Joins Temple Health as Thoracic Surgeon-in-Chief
By: Camryn Keeble
April 8, 2022
Mesothelioma specialist Dr. Joseph Friedberg was appointed the new Thoracic Surgeon-in-Chief of Temple University Health System and the affiliated Fox Chase Cancer Center. He will...
Read Post